If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

ACRS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.70%

Insider Buying (Last 12 Months): $50,310.00

Insider Selling (Last 12 Months): $4,188,162.15

Aclaris Therapeutics Insider Trading History Chart

Aclaris Therapeutics Share Price & Price History

^$8.24

▲ +0.29 (3.65%)

As of 03/21/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Aclaris Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/9/2023	Douglas J Manion	CEO	Buy	6,500	$7.74	$50,310.00	6,500
3/2/2023	Joseph Monahan	Insider	Sell	14,800	$12.37	$183,076.00	151,261
3/2/2023	Kevin Balthaser	CFO	Sell	1,000	$12.29	$12,290.00	4,650
3/2/2023	Neal Walker	Director	Sell	29,000	$12.37	$358,730.00	1,285,188
2/8/2023	James Loerop	Insider	Sell	4,267	$13.89	$59,268.63	6,983
1/3/2023	Neal Walker	Director	Sell	25,000	$15.25	$381,250.00	1,220,763
12/15/2022	Joseph Monahan	Insider	Sell	5,000	$15.88	$79,400.00	96,386
10/26/2022	Andrew N Schiff	Director	Sell	14,540	$17.00	$247,180.00	488,381
10/24/2022	Andrew N Schiff	Director	Sell	14,616	$17.01	$248,618.16	514,939
10/17/2022	Andrew N Schiff	Director	Sell	19,944	$16.05	$320,101.20	561,648
10/17/2022	Joseph Monahan	Insider	Sell	5,000	$15.98	$79,900.00	101,386
10/6/2022	Andrew N Schiff	Director	Sell	37,839	$16.54	$625,857.06	588,916
10/4/2022	Andrew N Schiff	Director	Sell	7,700	$16.01	$123,277.00	626,755
6/17/2022	Andrew N. Schiff	Director	Sell	19,565	$15.14	$296,214.10
4/25/2022	Neal Walker	CEO	Sell	20,000	$15.18	$303,600.00	1,245,763
4/21/2022	Neal Walker	CEO	Sell	25,000	$15.24	$381,000.00	1,290,763
4/18/2022	Joseph Monahan	Insider	Sell	30,000	$16.28	$488,400.00	106,386
3/11/2022	Neal Walker	CEO	Sell	56,303	$15.91	$895,780.73
3/10/2022	Frank Ruffo	CFO	Sell	12,823	$15.55	$199,397.65
3/10/2022	Joseph Monahan	Insider	Sell	27,165	$15.71	$426,762.15
2/9/2022	Joseph Monahan	Insider	Sell	383	$12.68	$4,856.44
7/13/2021	David N. Gordon	Insider	Sell	2,631	$16.98	$44,674.38	147,447
6/3/2021	Kamil Ali-Jackson	Insider	Sell	9,492	$21.96	$208,444.32	122,196
6/2/2021	Neal Walker	CEO	Sell	33,260	$21.64	$719,746.40	1,265,442
6/1/2021	David N. Gordon	Insider	Sell	14,000	$23.01	$322,140.00	195,992
5/7/2021	Kamil Ali-Jackson	Insider	Sell	5,416	$23.52	$127,384.32	158,618
5/5/2021	Kamil Ali-Jackson	Insider	Sell	15,000	$23.98	$359,700.00	158,618
5/3/2021	Kamil Ali-Jackson	Insider	Sell	15,000	$24.59	$368,850.00	158,618
4/26/2021	Frank Ruffo	CFO	Sell	27,339	$25.80	$705,346.20	209,059
4/22/2021	Frank Ruffo	CFO	Sell	30,000	$26.84	$805,200.00	209,059

Big Potential, Tiny Penny Stock

From Health Sector Insight | Ad

Little-known stock ready to disrupt the $4.37 trillion wellness market

Click here to download the full report.

SEC Filings (Institutional Ownership Changes) for Aclaris Therapeutics (NASDAQ:ACRS)

95.33% of Aclaris Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aclaris Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/22/2023	Teachers Retirement System of The State of Kentucky	57,009	$0.90M	0.0%	+5.6%	0.085%
2/16/2023	Alliancebernstein L.P.	60,400	$0.95M	0.0%	+31.0%	0.091%
2/16/2023	Point72 Middle East FZE	4,788	$75K	0.0%	N/A	0.007%
2/16/2023	State of Wyoming	5,533	$87K	0.0%	N/A	0.008%
2/15/2023	MetLife Investment Management LLC	33,899	$0.53M	0.0%	+8.4%	0.051%
2/15/2023	Silverarc Capital Management LLC	352,193	$5.55M	1.6%	-35.2%	0.528%
2/15/2023	State of Wisconsin Investment Board	43,921	$0.69M	0.0%	-6.2%	0.066%
2/15/2023	Schonfeld Strategic Advisors LLC	412,238	$6.49M	0.1%	+3.0%	0.618%
2/15/2023	Laurion Capital Management LP	1,201,801	$18.93M	0.1%	-7.9%	1.802%
2/15/2023	Millennium Management LLC	207,898	$3.27M	0.0%	+2.0%	0.312%
2/15/2023	Morgan Stanley	140,404	$2.21M	0.0%	-16.3%	0.211%
2/15/2023	Algert Global LLC	13,830	$0.22M	0.0%	N/A	0.021%
2/15/2023	Alps Advisors Inc.	45,205	$0.71M	0.0%	N/A	0.068%
2/15/2023	AQR Capital Management LLC	14,336	$0.23M	0.0%	+28.4%	0.021%
2/15/2023	Braidwell LP	2,393,985	$37.71M	1.3%	N/A	3.590%
2/14/2023	Point72 Asset Management L.P.	1,782,600	$28.08M	0.1%	-3.8%	2.673%
2/14/2023	Verition Fund Management LLC	405,568	$6.39M	0.1%	+8.9%	0.608%
2/14/2023	Two Sigma Investments LP	10,700	$0.17M	0.0%	N/A	0.016%
2/13/2023	Charles Schwab Investment Management Inc.	412,133	$6.49M	0.0%	+2.4%	0.618%
2/13/2023	Deutsche Bank AG	1,177,593	$18.55M	0.0%	+0.7%	1.766%
2/13/2023	Wells Fargo & Company MN	7,586	$0.12M	0.0%	+24.2%	0.011%
2/13/2023	Barclays PLC	42,810	$0.67M	0.0%	+156.2%	0.064%
2/13/2023	Renaissance Technologies LLC	1,121,752	$17.67M	0.0%	-5.4%	1.682%
2/13/2023	The Manufacturers Life Insurance Company	24,926	$0.39M	0.0%	+6.6%	0.037%
2/13/2023	ExodusPoint Capital Management LP	14,753	$0.23M	0.0%	N/A	0.022%
2/13/2023	Credit Suisse AG	64,972	$1.02M	0.0%	+57.0%	0.097%
2/13/2023	Geode Capital Management LLC	1,058,748	$16.68M	0.0%	+2.9%	1.588%
2/13/2023	JPMorgan Chase & Co.	427,660	$6.74M	0.0%	-5.6%	0.641%
2/10/2023	Bank of America Corp DE	81,118	$1.28M	0.0%	+13.0%	0.122%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	16,846	$0.27M	0.0%	-37.3%	0.025%
2/10/2023	HRT Financial LP	45,535	$0.72M	0.0%	N/A	0.068%
2/10/2023	Cheyne Capital Management UK LLP	50,964	$0.80M	1.4%	N/A	0.076%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	31,135	$0.49M	0.0%	+16.6%	0.047%
2/9/2023	Aisling Capital Management LP	434,455	$6.84M	4.5%	-31.5%	0.652%
2/9/2023	Principal Financial Group Inc.	18,208	$0.29M	0.0%	+11.0%	0.027%
2/9/2023	Citigroup Inc.	18,286	$0.29M	0.0%	+120.8%	0.027%
2/9/2023	HighTower Advisors LLC	192,424	$3.03M	0.0%	+229.8%	0.289%
2/8/2023	Swiss National Bank	112,600	$1.77M	0.0%	+1.9%	0.169%
2/7/2023	Fox Run Management L.L.C.	16,350	$0.26M	0.1%	+9.5%	0.025%
2/7/2023	Handelsbanken Fonder AB	14,800	$0.23M	0.0%	N/A	0.022%
2/3/2023	Frazier Life Sciences Management L.P.	290,189	$4.57M	0.3%	-28.9%	0.435%
2/2/2023	SG Americas Securities LLC	7,361	$0.12M	0.0%	-45.9%	0.011%
2/2/2023	ProShare Advisors LLC	13,828	$0.22M	0.0%	+8.6%	0.021%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	9,759	$0.15M	0.0%	+30.1%	0.015%
1/26/2023	Strs Ohio	36,400	$0.57M	0.0%	+82.9%	0.055%
1/23/2023	Allspring Global Investments Holdings LLC	65,307	$1.03M	0.0%	-1.3%	0.098%
12/8/2022	Bank of New York Mellon Corp	233,882	$3.68M	0.0%	+15.7%	0.351%
11/22/2022	Teachers Retirement System of The State of Kentucky	54,011	$0.85M	0.0%	N/A	0.081%
11/21/2022	California State Teachers Retirement System	65,616	$1.03M	0.0%	+5.8%	0.098%
11/16/2022	Balyasny Asset Management LLC	106,147	$1.67M	0.0%	N/A	0.159%
11/16/2022	BNP Paribas Arbitrage SNC	21,074	$0.33M	0.0%	+57.8%	0.032%
11/15/2022	State Street Corp	1,303,027	$20.51M	0.0%	+5.9%	1.954%
11/15/2022	Vanguard Group Inc.	2,931,709	$46.15M	0.0%	+4.2%	4.396%
11/15/2022	Price T Rowe Associates Inc. MD	47,106	$0.74M	0.0%	+23.9%	0.071%
11/15/2022	Parkman Healthcare Partners LLC	233,626	$3.68M	1.0%	-23.4%	0.350%
11/15/2022	Laurion Capital Management LP	1,304,624	$20.54M	0.1%	-9.4%	1.957%
11/15/2022	Ensign Peak Advisors Inc	15,950	$0.25M	0.0%	+45.4%	0.024%
11/15/2022	Bank of New York Mellon Corp	233,882	$3.68M	0.0%	+15.7%	0.351%
11/15/2022	BlackRock Inc.	4,810,298	$75.71M	0.0%	+3.0%	7.214%
11/15/2022	Citadel Advisors LLC	1,118,417	$17.60M	0.0%	+17.3%	1.677%
11/14/2022	Point72 Asset Management L.P.	1,853,251	$29.17M	0.1%	+6.9%	2.779%
11/14/2022	Cubist Systematic Strategies LLC	8,109	$0.13M	0.0%	-10.4%	0.012%
11/14/2022	Renaissance Technologies LLC	1,185,178	$18.66M	0.0%	-10.9%	1.777%
11/14/2022	Verition Fund Management LLC	372,507	$5.86M	0.1%	+11.3%	0.559%
11/14/2022	Nuveen Asset Management LLC	221,424	$3.49M	0.0%	-11.7%	0.332%
11/14/2022	AXA S.A.	18,200	$0.29M	0.0%	N/A	0.027%
11/14/2022	Integral Health Asset Management LLC	340,000	$5.35M	1.0%	+18.9%	0.510%
11/10/2022	Credit Suisse AG	41,392	$0.65M	0.0%	+12.0%	0.062%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	26,854	$0.42M	0.0%	N/A	0.040%
11/10/2022	Dimensional Fund Advisors LP	48,017	$0.76M	0.0%	N/A	0.072%
11/10/2022	Tower Research Capital LLC TRC	7,931	$0.13M	0.0%	-39.9%	0.012%
11/9/2022	Amalgamated Bank	10,453	$0.17M	0.0%	+10.6%	0.016%
11/8/2022	Allianz Asset Management GmbH	21,800	$0.34M	0.0%	-78.2%	0.033%
11/8/2022	New York State Common Retirement Fund	46,808	$0.74M	0.0%	+20.5%	0.070%
11/7/2022	Fox Run Management L.L.C.	14,928	$0.24M	0.1%	N/A	0.022%
11/7/2022	Arizona State Retirement System	12,665	$0.20M	0.0%	+9.0%	0.019%
11/7/2022	ProShare Advisors LLC	12,730	$0.20M	0.0%	+6.9%	0.019%
11/3/2022	Barclays PLC	16,707	$0.26M	0.0%	-24.0%	0.025%
11/1/2022	Great West Life Assurance Co. Can	1,944	$31K	0.0%	N/A	0.003%
10/31/2022	SG Americas Securities LLC	13,598	$0.21M	0.0%	N/A	0.020%
10/28/2022	Silverarc Capital Management LLC	543,776	$8.56M	2.9%	+0.8%	0.816%
10/27/2022	Assenagon Asset Management S.A.	194,923	$3.07M	0.0%	-33.5%	0.292%
10/27/2022	Strs Ohio	19,900	$0.31M	0.0%	+11.2%	0.030%
10/26/2022	Allspring Global Investments Holdings LLC	66,136	$1.04M	0.0%	N/A	0.099%
8/30/2022	Verition Fund Management LLC	334,666	$4.67M	0.1%	+31.0%	0.502%
8/22/2022	Legal & General Group Plc	17,689	$0.25M	0.0%	+6.6%	0.027%
8/18/2022	Goldman Sachs Group Inc.	407,889	$5.69M	0.0%	+57.8%	0.612%
8/16/2022	Woodline Partners LP	621,557	$8.68M	0.1%	N/A	0.932%
8/16/2022	Price T Rowe Associates Inc. MD	38,029	$0.53M	0.0%	+20.5%	0.057%
8/16/2022	Commodore Capital LP	2,410,622	$33.65M	7.1%	+4.1%	3.616%
8/15/2022	State Street Corp	1,230,241	$17.17M	0.0%	+13.6%	1.845%
8/15/2022	Acuta Capital Partners LLC	192,835	$2.69M	1.5%	-11.4%	0.289%
8/15/2022	Cubist Systematic Strategies LLC	9,050	$0.13M	0.0%	+163.9%	0.014%
8/15/2022	Point72 Asset Management L.P.	1,733,900	$24.21M	0.1%	-23.9%	2.601%
8/15/2022	Citadel Advisors LLC	953,072	$13.31M	0.0%	-2.0%	1.429%
8/15/2022	Millennium Management LLC	198,794	$2.78M	0.0%	+253.6%	0.298%
8/15/2022	UBS Asset Management Americas Inc.	86,267	$1.20M	0.0%	+74.8%	0.129%
8/13/2022	Renaissance Technologies LLC	1,329,678	$18.56M	0.0%	-8.8%	1.994%
8/13/2022	American International Group Inc.	28,001	$0.39M	0.0%	+10.6%	0.042%
8/12/2022	Northern Trust Corp	523,679	$7.31M	0.0%	+11.4%	0.785%

Data available starting January 2016

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments. The Therapeutics segment focuses on identifying, developing, and commercializing different therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.

Today's Range

Now: $8.24

$7.89

$8.32

50 Day Range

MA: $13.15

$7.07

$17.95

52 Week Range

Now: $8.24

$5.77

$18.96

Volume

482,111 shs

Average Volume

1,106,891 shs

Market Capitalization

$549.53 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.6

Who are the company insiders with the largest holdings of Aclaris Therapeutics?: Aclaris Therapeutics' top insider shareholders include:
Neal Walker (CEO)
Neal Walker (Director)
Andrew N Schiff (Director)
Frank Ruffo (CFO)
David N Gordon (Insider)
Kamil Ali-Jackson (Insider)
Joseph Monahan (Insider)
James Loerop (Insider)
Douglas J Manion (CEO)
Kevin Balthaser (CFO)
Andrew N Schiff (Director)
Learn More about top insider investors at Aclaris Therapeutics.
Who are the major institutional investors of Aclaris Therapeutics?: Aclaris Therapeutics' top institutional investors include:
Braidwell LP — 3.59%
Point72 Asset Management L.P. — 2.67%
Laurion Capital Management LP — 1.80%
Deutsche Bank AG — 1.77%
Renaissance Technologies LLC — 1.68%
Geode Capital Management LLC — 1.59%
Learn More about top institutional investors of Aclaris Therapeutics stock.
Which major investors are selling Aclaris Therapeutics stock?: Within the last quarter, ACRS stock was sold by these institutional investors:
Aisling Capital Management LP
Silverarc Capital Management LLC
Frazier Life Sciences Management L.P.
Laurion Capital Management LP
Point72 Asset Management L.P.
Renaissance Technologies LLC
Morgan Stanley
JPMorgan Chase & Co.
Within the previous year, company insiders that have sold Aclaris Therapeutics company stock include:
Neal Walker (CEO)
Neal Walker (Director)
Andrew N Schiff (Director)
Frank Ruffo (CFO)
David N Gordon (Insider)
Kamil Ali-Jackson (Insider)
Joseph Monahan (Insider)
Learn More investors selling Aclaris Therapeutics stock.
Which major investors are buying Aclaris Therapeutics stock?: During the previous quarter, ACRS stock was acquired by institutional investors including:
Braidwell LP
HighTower Advisors LLC
Cheyne Capital Management UK LLP
HRT Financial LP
Alps Advisors Inc.
Verition Fund Management LLC
Geode Capital Management LLC
Barclays PLC